Fu Wei

Policy reform, new models and cross-border platforms make the region a key driver of biopharma innovation

Three factors are driving the industry’s market outperformance in Asia

Successful execution of buyout strategies requires a hands-on approach to manage investments effectively

While Covid-19 cast a spotlight on the challenges that healthcare systems face throughout the region, there has long been an unmet need in South-east Asia.